期刊
STEM CELL REVIEWS AND REPORTS
卷 8, 期 2, 页码 375-392出版社
SPRINGER
DOI: 10.1007/s12015-011-9312-0
关键词
Stem cells; Immunosuppression; Mesenchymal stem cells; Immune modulation
资金
- KAIMRC [RC08/114]
- KACST [ARP-29-186]
- NHMRC [509178]
- RWH Foundation
- Cecilia Kilkeary Foundation
- Eirene Lucas Foundation
- Harold & Cora Brennen Benevolent Trust
- Jack Brockhoff Foundation
- J & R McGauran Charitable Trust
- Diana Brown Trust
- Helen Macpherson Smith Trust
- Thomas R & Rosalinda B Ditchfield Medical Research Endowment
- Wenkart Foundation
Mesenchymal stem cells (MSC) can be isolated from different adult tissues including bone marrow, adipose tissue, cord blood and placenta. MSCs modulate the immune function of the major immune cell populations involved in alloantigen recognition and elimination, including antigen presenting cells, T cells, B cells and natural killer cells. Many clinical trials are currently underway that employ MSCs to treat human immunological diseases. However, the molecular mechanism that mediates the immunosuppressive effect of MSCs is still unclear and the safety of using MSC in patient needs further confirmation. Here, we review the cytokines that activate MSCs and the soluble factors produced by MSCs, which allow them to exert their immunosuppressive effects. We review the mechanism responsible, at least in part, for the immune suppressive effects of MSCs and highlight areas of research required for a better understanding of MSC immune modulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据